Biosimilar Impact on Oncology Clinical Trial Design and Operations

JCO Oncol Pract. 2022 Mar;18(3):157-160. doi: 10.1200/OP.21.00583. Epub 2021 Oct 1.

Authors

Jason Chen¹, Dat Ngo¹, Annie Yi¹

Affiliation

¹ City of Hope National Medical Center, Duarte, CA.

PMID: 34597161
DOI: 10.1200/OP.21.00583

No abstract available

Publication types

Editorial

MeSH terms

Biosimilar Pharmaceuticals* / pharmacology
Biosimilar Pharmaceuticals* / therapeutic use
Clinical Trials as Topic
Humans
Medical Oncology
Neoplasms* / complications
Neoplasms* / drug therapy

Substances

Biosimilar Pharmaceuticals